Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies.  

We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja

Biotechnology

Health Care

Life Sciences

Medical Devices

Therapeutics

Be The Match BioTherapies

Be The Match BioTherapies' headquarters in Minneapolis, MN, United States

Amy Ronneberg

Julie Tilbury

Molly Mjolsness Mba

Chris McClain

The Sales and Business Development team at Be The Match BioTherapies focuses on cultivating partnerships with cell and gene therapy companies, growing business opportunities, and expanding the reach of the company’s cellular therapy solutions. They identify new markets, negotiate contracts, and build strategic alliances to enhance the company’s impact in the cell and gene therapy sector.

About

People (3)

Chris McClain

Eck Redmond

Matt Mayr

Jobs